The Therapeutic Goods Administration has issued a safety warning for a rare, but serious risk of vision impairment from taking GLP-1-based drugs such as Ozempic and Wegovy.
You are being forwarded to ABC Arts in a few seconds. Renegade Enterprises is a news aggregator — we credit, link, and attribute every story to its original publisher. If you are the rights holder and want this link removed, use our DMCA process.